DEUTSCHE BANK AG\ - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 219 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$6,157,364
-48.6%
468,597
-50.7%
0.00%
-33.3%
Q2 2023$11,971,878
-42.1%
950,149
-40.0%
0.01%
-50.0%
Q1 2023$20,665,614
+11.9%
1,583,572
+51.3%
0.01%
+9.1%
Q4 2022$18,467,544
+38.6%
1,046,913
+19.7%
0.01%
+37.5%
Q3 2022$13,322,000
+45.5%
874,756
+41.6%
0.01%
+60.0%
Q2 2022$9,159,000
-41.3%
617,615
-10.9%
0.01%
-28.6%
Q1 2022$15,609,000
+114.7%
693,113
+75.9%
0.01%
+133.3%
Q4 2021$7,271,000
+16.7%
394,093
-15.4%
0.00%0.0%
Q3 2021$6,228,000
-11.1%
465,766
+23.1%
0.00%0.0%
Q2 2021$7,006,000
-30.4%
378,501
-43.5%
0.00%
-40.0%
Q1 2021$10,063,000
+65.2%
670,246
+58.9%
0.01%
+25.0%
Q4 2020$6,092,000
+31.5%
421,806
-25.9%
0.00%
+33.3%
Q3 2020$4,633,000
+19.9%
569,189
-0.3%
0.00%0.0%
Q2 2020$3,864,000
-6.0%
570,841
-2.3%
0.00%
-25.0%
Q1 2020$4,112,000
+39.2%
583,986
+94.0%
0.00%
+100.0%
Q4 2019$2,953,000
-17.7%
301,077
-7.9%
0.00%0.0%
Q3 2019$3,589,000
-46.7%
326,946
-43.6%
0.00%
-50.0%
Q2 2019$6,735,000
-5.4%
579,371
-22.4%
0.00%0.0%
Q1 2019$7,116,000
+7.0%
746,258
+8.1%
0.00%
-20.0%
Q4 2018$6,651,000
-85.5%
690,158
-78.6%
0.01%
-61.5%
Q3 2018$45,879,000
-7.9%
3,219,775
-22.4%
0.01%
-7.1%
Q2 2018$49,791,000
+194.2%
4,149,411
+202.7%
0.01%
+75.0%
Q1 2018$16,925,000
-32.8%
1,370,736
-20.8%
0.01%
-50.0%
Q4 2017$25,179,000
+27.7%
1,730,780
+24.9%
0.02%
+14.3%
Q3 2017$19,717,000
-27.8%
1,385,758
-35.2%
0.01%
-26.3%
Q2 2017$27,294,000
+12.8%
2,139,288
+12.1%
0.02%
+5.6%
Q1 2017$24,201,000
+68.3%
1,908,848
+35.5%
0.02%
+50.0%
Q4 2016$14,382,000
-25.8%
1,408,672
-4.2%
0.01%
-14.3%
Q3 2016$19,372,000
+21.3%
1,471,037
+16.9%
0.01%
+27.3%
Q2 2016$15,972,000
+9.2%
1,257,879
+13.6%
0.01%0.0%
Q1 2016$14,628,000
-19.6%
1,107,532
-6.4%
0.01%
-15.4%
Q4 2015$18,190,000
+56.8%
1,182,837
+26.4%
0.01%
+44.4%
Q3 2015$11,599,000
-28.0%
935,609
-20.6%
0.01%
-10.0%
Q2 2015$16,117,000
-21.5%
1,178,375
-31.4%
0.01%
-23.1%
Q1 2015$20,530,000
+15.0%
1,716,880
+22.8%
0.01%
+18.2%
Q4 2014$17,845,000
+21.5%
1,397,586
+27.6%
0.01%
+22.2%
Q3 2014$14,687,000
-8.3%
1,094,956
+9.7%
0.01%
-18.2%
Q2 2014$16,018,000
-10.5%
998,184
+0.5%
0.01%
-15.4%
Q1 2014$17,903,000
+0.5%
993,053
-13.9%
0.01%0.0%
Q4 2013$17,822,000
-2.9%
1,152,864
-6.6%
0.01%
-7.1%
Q3 2013$18,346,0001,233,9420.01%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q4 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders